Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.

Ram, Z.; Kim, C.Y.; Hottinger, A.F.; Idbaih, A.; Nicholas, G.; Zhu, J.J.

doi:10.3389/fonc.2022.902929

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.

Details

Request a copy

Serval ID

serval:BIB_CC8D1F6C6D1E

Type

Article: article from journal or magazin.

Publication sub-type

Letter (letter): Communication to the publisher.

Collection

Publications

Institution

UNIL/CHUV

Title

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.

Journal

Frontiers in oncology

Author(s)

Ram Z., Kim C.Y., Hottinger A.F., Idbaih A., Nicholas G., Zhu J.J.

ISSN

2234-943X (Print)

ISSN-L

2234-943X

Publication state

Published

Issued date

2022

Peer-reviewed

Oui

Volume

12

Pages

902929

Language

english

Notes

Publication types: Published Erratum
Publication Status: epublish

Keywords

Cancer Research, Oncology, TTFields, Tumor Treating Fields, efficacy and safety, elderly patients, newly diagnosed glioblastoma, phase 3 clinical trial, quality-of-life, temozolomide

OAI-PMH

oai:serval.unil.ch:BIB_CC8D1F6C6D1E

DOI

10.3389/fonc.2022.902929

Pubmed

35494031

Web of science

000792748900001

Open Access

Yes

Create date

31/03/2023 9:45